Design of a prospective clinical study on the agreement between the Continuous GlucoseMonitor, a novel device for CONTinuous ASSessment of blood GLUcose levels, and the RAPIDLab® 1265 blood gas analyser: The CONTASSGLU study

BACKGROUND: Although a device is needed to continuously measure blood glucose levels within an intensive care setting, and several large-scale prospective studies have shown that patients might benefit from intensive insulin, potassium, or glucose therapy during intensive care, no devices are curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmermann, Johannes B, Lehmann, Monika, Hofer, Stefan, Hüsing, Johannes, Alles, Catharina, Werner, Jens, Stiller, Jürgen, Künnecke, Wolfgang, Luntz, Steffen, Motsch, Johann, Weigand, Markus A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532142/
https://www.ncbi.nlm.nih.gov/pubmed/22998112
http://dx.doi.org/10.1186/1471-2253-12-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532142/
https://www.ncbi.nlm.nih.gov/pubmed/22998112
http://dx.doi.org/10.1186/1471-2253-12-24

Ejemplares similares